Candel Therapeutics, Inc. - 8-K Filing

Candel Therapeutics filed an investor presentation under Regulation FD disclosure, highlighting its pipeline and financial position. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $CADL

Read the full article at SEC EDGAR

More Regulatory news